Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study

Research output: Contribution to journalArticle

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study'. Together they form a unique fingerprint.

Medicine & Life Sciences